The Role of AI in Modernizing Clinical Trials: From Patient Selection to Data Management

Clicks: 1
ID: 309211
2024
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #153 of 153 articles by views in International Journal of Pharmaceutical Drug Design (IJPDD)

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 153 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Aim: This study aimed at researching the transformative role that artificial intelligence has played in making clinical trials more efficient and effective-particularly concerning patient selection, trial design, and data management. Purpose: The main objective for this study will be to search, identify, and critically analyze various AI technologies in machine learning, natural language processing, predictive analytics, and their corresponding applications in clinical trials, focusing on using these novel approaches to bypass inefficiencies of the traditional approach and improve the outcomes of a clinical trial. Method: A descriptive research design was used, drawing on a standardized online survey conducted among 200 professionals involved in clinical trials. The survey collected the following: some relatively objective numerical data regarding the use of AI tools and problems encountered while managing data, as well as perceived outcomes from the inclusion of AI in clinical trials. Result: The key findings were that machine learning algorithms dominated with 40%, while the natural language processing aspect represented 30%. Among the challenges noted regarding data management was the integration of data, that reached 35% and quality of data is also at 30%. AI-driven outcomes improved patient selection and the efficiency of trial design. Conclusion: Integration of AI technologies in clinical trials would modernize research practices, meet the challenge of data management, and generally improve the efficiency of a trial. The findings reflect that investment into such tools needs to continue so results from trials can be successful and healthcare solutions are continuously improved.
Reference Key
imported_1761926672_6904de109312e Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Dr. Anusha Dewan, Dr. Sanjeev Kumar, Namrata Bhutani, Dr. Rohit Kumar Tomer
Journal International Journal of Pharmaceutical Drug Design (IJPDD)
Year 2024
DOI
10.62896/ijpdd.1.12.1
URL
https://ijpdd.org/index.php/files/article/view/177
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.